Pressmeddelanden

2016-12-26

Starting December 2016 Lipigon joins the AZ BioVentureHub located at AstraZeneca's site in Mölndal, Sweden. The contract stretches over 1 year giving Lipigon an office and full access to the whole facility, including infrastructure and capabilities.

2016-12-01

Lipigon is happy to announce 3 new major partners investing in the company. Umeå based Fort Knox Förvaltning AB (Owner of Balticgruppen) and Partnerinvest Övre Norrland AB together with Antaros Medical AB in Gothenburg have entered as new shareholders. The investments allow for Lipigon to expand within present programs and to evaluate novel targets.

2016-03-13

Lipigon Pharmaceuticals today announced that it has entered into a research collaboration with AstraZeneca to conduct joint research to identify drug candidates that promote the stabilization of Lipoprotein Lipase (LPL) and may have utility in the treatment of lipid disorders and cardiovascular disease.

Nyheter

14 september, 2021, Pressmeddelande

Analysguiden: Lipigon följer tidsplanen

Lipigon följer tidsplanen inför kommande kliniska studier med den första säkerhetsstudien nu avklara...

13 september, 2021, Pressmeddelande

Lipigon deltar på Umeå på börsen den 29 september

Umeåbaserade Lipigon Pharmaceuticals AB ("Lipigon") kommer att delta på eventet Umeå på börsen onsda...

10 september, 2021, Pressmeddelande

Lipigon tillkännager positiva resultat i förberedande preklinisk säkerhetsstudie för blodfettssänkande läkemedelskandidaten Lipisense

Lipigon Pharmaceuticals AB ("Lipigon"), som utvecklar nya behandlingar mot förhöjda blodfetter, så k...